153 related articles for article (PubMed ID: 11169146)
1. S-100-positive nerve fibers in hepatocellular carcinoma and intrahepatic cholangiocarcinoma: an immunohistochemical study.
Terada T; Matsunaga Y
Pathol Int; 2001 Feb; 51(2):89-93. PubMed ID: 11169146
[TBL] [Abstract][Full Text] [Related]
2. Increased mast cells in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Terada T; Matsunaga Y
J Hepatol; 2000 Dec; 33(6):961-6. PubMed ID: 11131459
[TBL] [Abstract][Full Text] [Related]
3. Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas.
Okamura N; Yoshida M; Shibuya A; Sugiura H; Okayasu I; Ohbu M
Pathol Int; 2005 Nov; 55(11):724-31. PubMed ID: 16271085
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1.
Radwan NA; Ahmed NS
Diagn Pathol; 2012 Oct; 7():149. PubMed ID: 23111165
[TBL] [Abstract][Full Text] [Related]
5. Double cancer - hepatocellular carcinoma and intrahepatic cholangiocarcinoma with a spindle-cell variant.
Itamoto T; Asahara T; Katayama K; Momisako H; Dohi K; Shimamoto F
J Hepatobiliary Pancreat Surg; 1999; 6(4):422-6. PubMed ID: 10664295
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of hepatocellular and adenocarcinoma in the liver: MOC31 compares favorably with other putative markers.
Porcell AI; De Young BR; Proca DM; Frankel WL
Mod Pathol; 2000 Jul; 13(7):773-8. PubMed ID: 10912937
[TBL] [Abstract][Full Text] [Related]
7. Combined hepatocellular and cholangiocarcinoma with marked squamous cell carcinoma components arising in non-cirrhotic liver.
Tsuneyama K; Kaizaki Y; Doden K; Kidani E; Harada K; Sasaki M; Nakanuma Y
Pathol Int; 2003 Feb; 53(2):90-7. PubMed ID: 12588436
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of immunohistochemical markers for differential diagnosis of hepatocellular carcinoma from intrahepatic cholangiocarcinoma].
Dong H; Cong WL; Zhu ZZ; Wang B; Xian ZH; Yu H
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):702-5. PubMed ID: 19173916
[TBL] [Abstract][Full Text] [Related]
9. Pathology of combined hepatocellular-cholangiocarcinoma.
Yeh MM
J Gastroenterol Hepatol; 2010 Sep; 25(9):1485-92. PubMed ID: 20796144
[TBL] [Abstract][Full Text] [Related]
10. Alpha-smooth muscle actin-positive stromal cells in cholangiocarcinomas, hepatocellular carcinomas and metastatic liver carcinomas.
Terada T; Makimoto K; Terayama N; Suzuki Y; Nakanuma Y
J Hepatol; 1996 Jun; 24(6):706-12. PubMed ID: 8835746
[TBL] [Abstract][Full Text] [Related]
11. Combined hepatocellular-cholangiocarcinoma. Cytologic findings in four cases.
Dusenbery D
Acta Cytol; 1997; 41(3):903-9. PubMed ID: 9167724
[TBL] [Abstract][Full Text] [Related]
12. Elevated expression of Bmi1 in hepatocellular carcinoma with bile duct tumor thrombi.
Zhang R; Xu LB; Zeng H; Yu XH; Wang J; Liu C
Hepatogastroenterology; 2013; 60(128):2042-7. PubMed ID: 24719948
[TBL] [Abstract][Full Text] [Related]
13. Microvessel density and angiogenesis in primary hepatic malignancies: Differential expression of CD31 and VEGFR-2 in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Bösmüller H; Pfefferle V; Bittar Z; Scheble V; Horger M; Sipos B; Fend F
Pathol Res Pract; 2018 Aug; 214(8):1136-1141. PubMed ID: 29935812
[TBL] [Abstract][Full Text] [Related]
14. Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Lee WS; Lee KW; Heo JS; Kim SJ; Choi SH; Kim YI; Joh JW
Surg Today; 2006; 36(10):892-7. PubMed ID: 16998683
[TBL] [Abstract][Full Text] [Related]
15. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma.
Shiran MS; Isa MR; Sherina MS; Rampal L; Hairuszah I; Sabariah AR
Malays J Pathol; 2006 Dec; 28(2):87-92. PubMed ID: 18376797
[TBL] [Abstract][Full Text] [Related]
16. Differential diagnosis of malignant epithelial tumours in the liver: an immunohistochemical study on liver biopsy material.
Al-Muhannadi N; Ansari N; Brahmi U; Satir AA
Ann Hepatol; 2011; 10(4):508-15. PubMed ID: 21911893
[TBL] [Abstract][Full Text] [Related]
17. A combined hepatocellular/cholangiocellular carcinoma with sarcomatoid features.
Papotti M; Sambataro D; Marchesa P; Negro F
Liver; 1997 Feb; 17(1):47-52. PubMed ID: 9062880
[TBL] [Abstract][Full Text] [Related]
18. Cholangiolocellular carcinoma: an innocent-looking malignant liver tumor mimicking ductular reaction.
Sempoux C; Fan C; Singh P; Obeidat K; Roayaie S; Schwartz M; Fiel MI; Thung SN
Semin Liver Dis; 2011 Feb; 31(1):104-10. PubMed ID: 21344355
[TBL] [Abstract][Full Text] [Related]
19. Histopathology of hepatocellular carcinoma.
Schlageter M; Terracciano LM; D'Angelo S; Sorrentino P
World J Gastroenterol; 2014 Nov; 20(43):15955-64. PubMed ID: 25473149
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of immunohistochemical markers for differential diagnosis of hepatocelluar carcinoma and cholangiocarcinoma.
Ryu HS; Lee K; Shin E; Kim SH; Jing J; Jung HY; Lee H; Jang JJ
Tumori; 2012; 98(4):478-84. PubMed ID: 23052165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]